【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, November 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, November 2013 14
2.2.1 Shire to Acquire ViroPharma for US$4.2 Billion 14
2.2.2 Salix Pharma Commences Cash Tender Offer to Acquire Santarus for US$2.6 Billion 15
2.2.3 Perrigo Completes Private Placement of Notes for US$2.3 Billion 16
2.2.4 CVS Caremark to Acquire Coram from Apria Healthcare for US$2.1 Billion 16
2.2.5 Mylan Completes Public Offering of Notes for US$2 Billion 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, November 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, November 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2013 20
3.1.1 Top M&A Deals in November 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, June 2013 – November 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, November 2013 25
3.2.1 Top Equity Offering Deals in November 2013 27
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, June 2013 – November 2013 28
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, November 2013 30
3.3.1 Top PE/VC Deals in November 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, November 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, November 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2013-November 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2013-November 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, November 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, June 2013 – November 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), November 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, November 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, June 2013 – November 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), June 2013 – November 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), June 2013 – November 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, November 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), November 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, November 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, November 2013 57
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, November 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), June 2013 – November 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), June 2013 – November 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), June 2013 – November 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, November 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, November 2013 70
6.2.1 Central Nervous System – Deals of the Month 72
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, November 2013 74
6.3.1 Immunology – Dealsof the Month 76
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, November 2013 77
6.4.1 Cardiovascular – Deal of the Month 79
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, November 2013 81
6.5.1 Infectious Diseases – Deals of the Month 83
6.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, November 2013 84
6.6.1 Metabolic Disorders – Deal of the Month 86
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, November 2013 88
6.7.1 Gastrointestinal – Deal of the Month 90
7 Deal Summary by Geography 91
7.1 Pharmaceuticals & Healthcare, North America Deals, November 2013 91
7.1.1 North America – Deals of the Month 93
7.2 Pharmaceuticals & Healthcare, Europe, Deals, November 2013 95
7.2.1 Europe – Deals of the Month 96
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, November 2013 98
7.3.1 Asia-Pacific – Deals of the Month 100
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, November 2013 101
7.4.1 Rest of the World – Deals of the Month 102
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 103
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, June 2013 – November 2013 103
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, June 2013 – November 2013 105
9 Further Information 107
9.1 Methodology 107
9.2 About GlobalData 108
9.3 Disclosure information 109
9.4 Disclaimer 109
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：November 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for November 2013 in Pharmaceuticals
■ 発行日：2013年12月15日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163262
■ 調査対象地域：グローバル
- 世界のオストミードレナージバッグ(人工瘻排液袋)市場動向（2014-2018）About Ostomy and types of Drainage Bags An ostomy is a surgically made opening (stoma) in the skin that allows the external excretion of waste products such as stools, mucus, and urine into a bag placed outside the body of the patient. This bag is known as an ostomy drainage bag. Ostomies are used for the treatment of intestinal and bladder diseases. These procedures are also used to treat inflamm …
- 無線M2M及び&IoT市場動向（2014 – 2020）：市場機会、課題、戦略Despite its low ARPU, the wireless M2M market has become a key focus of many mobile network operators as their traditional voice and data markets become saturated. Likewise, government and regulatory initiatives such as the EU initiatives to have a smart meter penetration level of 80% by 2020 and the mandatory inclusion of automotive safety systems such as eCall in all new car models, have also he …
- 殺虫剤のヨーロッパ市場The Europe insecticides market for waste management accounted for $14,739.3 million in 2018, and is anticipated to reach $23,368.3 million by 2026, registering a CAGR of 5.8% from 2019 to 2026.Waste is generated during the extraction of raw materials, processing of raw materials into intermediate & final products, consumption of final products, agricultural activities, and other human activities. …
- 酸化インジウムスズ（ITO）の世界市場2016-2020About Indium Tin Oxide (ITO) ITO is made of tin oxide and indium oxide in a ratio of 9:1 by weight. It is transparent and colorless when applied in thin layers. The compound accounts for about 90% of the overall transparent conductive market and is extensively employed in many electronic devices that are used for military, medicinal, automotive, and other purposes and require brilliant display and …
- 人工内耳（蝸牛インプラント）の世界市場2016-2020About Cochlear Implants A cochlear implant is a surgically implanted complex electronic device that helps overcome complications in the inner ear or cochlea. This implant consists of two major components: an external component known as the sound processor and an internal component known as the implant. The sound processor receives sound waves and processes them into detailed digital information. T …
- 世界の政府部門におけるITセキュリティ支出市場About IT Security Spending in the Government Sector In 2015, the global IT security spending in the government sector was in its growth stage and many government organizations adopted IT security solutions to improve their business operations and productivity. Increasing instances of identity theft, cybercrime, and insider fraud as well as increasing opportunities for hackers are compelling organi …
- 世界の民間ヘリコプター市場予測（2014-2024）Civil helicopters extend the reach and expand the capabilities of businesses, governments and security agencies. The positive impact of civil helicopters for entities that can afford to acquire and operate them remains compelling. However, purchases must also be weighed against the prevailing economic conditions. For decades, the civil helicopter market was one of the smallest segments in the aero …
- ガラス充填ナイロンの世界市場2019-2023Global Glass Filled Nylon Market: About this market Technavio’s glass filled nylon market analysis considers sales from automotive, industrial, electrical and electronics, and others. Our analysis also considers the sales of glass filled nylon in APAC, Europe, North America, South America, and MEA. In 2018, the automotive segment had a significant market share, and this trend is expected to contin …
- ナチュラルフレグランスの世界市場2019-2023Global Natural Fragrance Market: About this market Natural fragrances are complex fragrance compounds made of ingredients obtained from plants. Technavio’s natural fragrance market analysis considers sales from fine fragrance, household care, and personal care and cosmetics. Our analysis also considers the sales of natural fragrance in APAC, Europe, North America, South America, and MEA. In 2018, …
- ジェット燃料添加剤の世界市場2015-2019Technavio’s market research analyst predicts the jet fuel additives market to witness a steady growth at a CAGR of around 7% during the forecast period. The lower oil prices and the need for fuel efficient aircrafts are the key drivers behind the growth of this market. The use of high-performance additives helps in reducing the costs of maintenance, reduce coking issues and provide optimum high-pe …
- Nasal Congestion：グローバル臨床試験レビューH1, 2013Nasal Congestion Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, H1, 2013" provides data on the Nasal Congestion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasal Congestion. It includes an overview of the trial numbers and their recruitment statu …
- スペインの分子診断市場2014This report provides an overview of the Spanish molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment Market Structure Market Size, Growth, and Major Suppliers' Market Shares List of TablesMolec …
- セキュリティ情報およびイベント管理（SIEM）市場動向と予測（2014-2019）：ソリューション別分析Security Information and Event Management (SIEM) is the umbrella term that covers SIM (Security Information Management) and SEM (Security Event Management). The SEM involves correlation and real-time monitoring of log events, notifications and console views while SIM includes analysis, storage and reporting of log event data. The SIEM market in this report is defined as the summation of SIEM solut …
- 航空機用フォームの世界市場：PUフォーム、金属フォーム、PEフォーム、メラミンフォームAbout Aerospace Foams Aerospace foams are manufactured using various materials such as polyurethane (PU) foams, polyethylene (PE) foams, metal foams, melamine foams, and other types of foams, including polyvinylidene fluoride (PVDF), polyphenylsulfone (PPSU), silicones, polyetherimide (PEI), and polymethacrylimide (PMI). These foams are used in various applications such as seating, gaskets, seals, …
- ココナッツクリームの世界市場2017-2021ABSTRACTAbout Coconut Cream Coconut cream is a product which is similar to coconut milk but has less water content than coconut milk. The product can be diluted with water or used directly to make curries, sweets, desserts, puddings, and various other preparations. Coconut cream is used as an ingredient in bakery products and for flavoring food items. Chefs from all around the world are coming up …
